Tryptophan overloading activates brain regions involved with cognition, mood and anxiety

Anais da Academia Brasileira de Ciencias

Volumn 89, Issue 1, 2017, Pages 273-283

  Silva, Luana C A ^a   Viana, Milena B ^a   Andrade, José S ^a   Souza, Melyssa A ^a   Céspedes, Isabel C ^a   D’Almeida, Vânia ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Fos protein; Immunoreactivity; Serotonin; Tryptophan

Indexed keywords

ANTIDEPRESSANT AGENT; PROTEIN C FOS; SEROTONIN; TRYPTOPHAN;

AFFECT; ANIMAL; ANXIETY; BRAIN; COGNITION; DIET THERAPY; DIETARY SUPPLEMENT; DRUG EFFECTS; DRUG THERAPY; EVALUATION STUDY; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; PROCEDURES; REPRODUCIBILITY; TIME FACTOR; TREATMENT OUTCOME; WISTAR RAT;

AFFECT; ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANXIETY; BRAIN; COGNITION; DIET THERAPY; DIETARY SUPPLEMENTS; IMMUNOHISTOCHEMISTRY; MALE; PROTO-ONCOGENE PROTEINS C-FOS; RATS, WISTAR; REPRODUCIBILITY OF RESULTS; SEROTONIN; TIME FACTORS; TREATMENT OUTCOME; TRYPTOPHAN;

EID: 85017583527     PISSN: 00013765     EISSN: 16782690     Source Type: Journal    
DOI: 10.1590/0001-3765201720160177     Document Type: Article

References (69)

1. AKIRAV I AND MAROUN M. 2007. The role of the medial prefrontal cortex-amygdala circuit in stress effects on the extinction of fear. Neural Plast 2007: 30873.
2. ANDRISANO C, CHIESA A AND SERRETTI A. 2013. Newer antidepressants and panic disorder: a meta-analysis. Int Clin Psychopharmacol 28: 33-45.
3. ATTENBURROW MJ, WILLIAMS C, ODONTIADIS J, POWELL J, VAN DE OUDERAA F, WILLIAMS M AND COWEN PJ. 2003. The effect of a nutritional source of tryptophan on dieting-induced changes in brain 5-HT function. Psychol Med 33: 1381-1386.
4. AZMITIA EC. 2001. Modern views on an ancient chemical: Serotonin effects on cells proliferation, maturation, and apoptosis. Brain Res Bull 56: 413-424.
5. BANDELOW B et al. 2012. Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. Int J Psychiatry Clin Pract 16:77-84.
6. BANDELOW B, ANDERSEN HF AND DOLBERG OT. 2007. Escitalopram in the treatment of anxiety symptoms associated with depression. Depress Anxiety 24: 53-61.
7. BEHBEHANI MM. 1995. Functional characteristics of the midbrain periaqueductal gray. Prog Neurobiol 46: 575-605.
8. BULLITT E. 1990. Expression of c-fos-like protein as a marker for neuronal activity following noxious stimulation in the rat. J Comp Neurol 296: 517-530.
9. CESPEDES IC, DE OLIVEIRA AR, DA SILVA JM, DA SILVA AV, SITA LV AND BITTENCOURT JC. 2010. mRNA expression of corticotropin-releasing factor and urocortin 1 after restraint and foot shock together with alprazolam administration. Peptides 31(12): 2200-2208.
10. CLISSOLD KA, CHOI E AND PRATT WE. 2013. Serotonin 1A, 1B, and 7 receptors of the rat medial nucleus accumbens differentially regulate feeding, water intake, and locomotor activity. Pharmacol Biochem Behav 112: 96-103.
11. CUNLIFFE A, OBEID OA AND POWELL-TUCK J. 1998. A placebo controlled investigation of the effects of tryptophan or placebo on subjective and objective measures of fatigue. Eur J Clin Nutr 52: 425-430.
12. DEAKIN JF AND GRAEFF FG. 1991. 5-HT and mechanisms of defence. J Psychopharmacol 5: 305-315.
13. DEAKIN JFW AND GRAEFF FG. 1991. 5-HT and mechanisms of defence. J Psychopharmacol 5: 339-341.
14. DEL ARCO A AND MORA F. 2008. Prefrontal cortex-nucleus accumbens interaction: in vivo modulation by dopamine and glutamate in the prefrontal cortex. Pharmacol Biochem Behav 90: 226-235.
15. DEN BOER JA, BOSKER FJ AND SLAAP BR. 2000. Serotonergic drugs in the treatment of depressive and anxiety disorders. Hum Psychopharmacol 15: 315-336.
16. DREVETS WC, PRICE JL AND FUREY ML. 2008. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct 213: 93-118.
17. EPSTEIN J et al. 2006. Lack of ventral striatal response to positive stimuli in depressed versus normal subjects. Am J Psychiatry 163: 1784-1790.
18. FEKETE C AND LECHAN RM. 2014. Central regulation of hypothalamic-pituitary-thyroid axis under physiological and pathophysiological conditions. Endocr Rev 35: 159-194.
19. FERNSTROM JD. 1983. Role of precursor availability in control of monoamine biosynthesis in brain. Physiol Rev 63: 484-546.
20. FREDERICKS CA, KALMAR JH AND BLUMBERG HP. 2006. The role of the ventral prefrontal cortex in mood disorders. In: ZALD DH AND RAUCH SL (Eds), The Orbitofrontal Cortex. New York: Oxford University Press, p. 544-577.
21. FUSTER J. 2001. The prefrontal cortex--an update: time is of the essence. Neuron 30: 319-333.
22. FUSTER JM. 1997. The Prefrontal Cortex- Anatomy, physiology and neuropsychology of the frontal lobe. Philadelphia-New York: Linpicott-Raven.
23. GLASS JD, SELIM M, SRKALOVIC G AND REA MA. 1995. Tryptophan loading modulates light-induced responses in the mammalian circadian system. J Biol Rhythms 10: 80-90.
24. GRAEFF FG. 2002. On serotonin and experimental anxiety. Psychopharmacology 163: 467-476.
25. GRAEFF FG, GUIMARÃES FS, DE ANDRADE TG AND DEAKIN JF. 1996. Role of 5-HT in stress, anxiety, and depression. Pharmacol Biochem Behav 54: 129-141.
26. GROENEWEGEN HJ AND UYLINGS HB. 2000. The prefrontal cortex and the integration of sensory, limbic and autonomic information. Prog Brain Res 126: 3-28
27. GUNDLAH C, PECINS-THOMPSON M, SCHUTZER WE AND BETHEA CL. 1999. Ovarian steroid effects on serotonin 1A, 2A and 2C receptor mRNA in macaque hypothalamus. Mol Brain Res 63: 325-339.
28. HALE MW, BOUWKNECHT JA, SPIGA F, SHEKHAR A AND LOWRY CA. 2006. Exposure to high- and low-light conditions in an open-field test of anxiety increases c-Fos expression in specific subdivisions of the rat basolateral amygdaloid complex. Brain Res Bull 71: 174-182.
29. HALE MW, SHEKHAR A AND LOWRY CA. 2012. Stress-related serotonergic systems: implications for symptomatology of anxiety and affective disorders. Cell Mol Neurobiol 32: 695-708.
30. HAYASHI M, SHIRAI Y, BANDOH T, IWAMASA K, SHINDOME N AND HOSHI K. 2006. Alteration of 5-HIAA levels in frontal cortex and dorsal raphe nucleus in rats treated with combined administration of tryptophan and ethanol. J Toxicol Sci 31: 235-246.
31. HEISLER LK et al. 2002. Activation of central melanocortin pathways by fenfluramine. Science 297: 609-611.
32. HEISLER LK et al. 2006. Serotonin reciprocally regulates melanocortin neurons to modulate food intake. Neuron 51: 239-249.
33. HELLER AS, JOHNSTONE T, SHACKMAN AJ, LIGHT SN, PETERSON MJ, KOLDEN GG, KALIN NH AND DAVIDSON RJ. 2009. Reduced capacity to sustain positive emotion in major depression reflects diminished maintenance of fronto-striatal brain activation. Proc Natl Acad Sci U S A 106: 22445-22450.
34. HOMBERG JR. 2012. Serotonin and decision making processes. Neurosci Biobehav Rev 36: 218-236.
35. HSU SM AND RAINE L. 1981. Protein A, avidin, and biotin in immunohistochemistry. J Histochem Cytochem 29: 1349-1353.
36. JACOBS BL AND AZMITIA EC. 1992. Structure and function of the brain serotonin system. Physiol Rev 72: 165-229.
37. JACOBS BL AND FORNAL CA. 1993. 5-HT and motor control: a hypothesis. Trends Neurosci 16: 346-352.
38. JACOBS BL AND FORNAL CA. 1999. Activity of serotonergic neurons in behaving animals. Neuropsychopharmacology 21: S9-15
39. JIA Y, EL-HADDAD M, GENDY A, NGUYEN T AND ROSS MG. 2010. Serotonin-induced region-specific responses of the arcuate and ventromedial hypothalamic nuclei. Int J Neurosci 120: 386-395.
40. KISER D, STEEMER SB, BRANCHI I AND HOMBERG JR. 2012. The reciprocal interaction between serotonin and social behavior. Neurosci Biobehav Rev 36: 786-798.
41. KLAASSEN T, KLUMPERBEEK J, DEUTZ NE, VAN PRAAG HM AND GRIEZ E. 1998. Effects of tryptophan depletion on anxiety and on panic provoked by carbon dioxide challenge. Psychiatry Res 77: 167-174.
42. KOTAGALE NR, UPADHYA M, HADOLE PN, KOKARE DM AND TAKSANDE BG. 2014. Involvement of hypothalamic neuropeptide Y in pentazocine induced suppression of food intake in rats. Neuropeptides 48: 133-141.
43. LAM DD, GARFIELD AS, MARSTON OJ, SHAW J AND HEISLER LK. 2010. Brain serotonin system in the coordination of food intake and body weight. Pharmacol Biochem Behav 97: 84-91.
44. LIEBERMAN HR, CORKIN S, SPRING BJ, WURTMAN RJ AND GROWDON JH. 1985. The effects of dietary neurotransmitter precursors on human behavior. Am J Clin Nutr 42: 366-370.
45. MANIAM J AND MORRIS MJ. 2012. The link between stress and feeding behavior. Neuropharmacology 63: 97-110.
46. MARKUS CR, FIRK C, GERHARDT C, KLOEK J AND SMOLDERS GF. 2008. Effect of different tryptophan sources on amino acids availability to the brain and mood in healthy volunteers. Psychopharmacology (Berl) 201: 107-114.
47. MARSH DM, DOUGHERTY DM, MOELLER FG, SWANN AC AND SPIGA R. 2002. Laboratory-measured aggressive behavior of women: acute tryptophan depletion and augmentation. Neuropsychopharmacology 26: 660-671.
48. MILAD MR AND QUIRK GJ. 2002. Neurons in medial prefrontal cortex signal memory for fear extinction. Nature 420: 70-74.
49. MILAD MR AND RAUCH SL. 2006. The orbitofrontal cortex and anxiety disorders. In: ZALD DH AND Rauch SL (Eds), The Orbitofrontal Cortex. New York: Oxford University Press, p. 523-543.
50. MILLER EK AND COHEN JD. 2001. An integrative theory of prefrontal cortex function. Annu Rev Neurosci 24:167-202.
51. MILLER HE, DEAKIN JF AND ANDERSON IM. 2000. Effect of acute tryptophan depletion on CO2-induced anxiety in patients with panic disorder and normal volunteers. Br J Psychiatry 176: 182-188.
52. MOLLIVER ME. 1987. Serotonergic neuronal systems: what their anatomic organization tells us about function. J Clin Psychopharmacol 7: 3S-23S.
53. MOREIRA FA AND GUIMARÃES FS. 2005. Role of serotonin receptors in panic-like behavior induced by nitric oxide in the rat dorsolateral periaqueductal gray: Effects of chronic clomipramine treatment. Life Sci 77: 1972-1982.
54. MYERS-SCHULZ B AND KOENIGS M. 2012. Functional anatomy of ventromedial prefrontal cortex: Implications for mood and anxiety disorders. Mol Psychiatry 17: 132-141.
55. PAXINOS G AND WATSON C. 2007. The rat brain in stereotaxic coordinates. New York: Academic Press.
56. PRICE JL AND DREVETS WC. 2010. Neurocircuitry of mood disorders. Neuropsychopharmacology 35: 192-216.
57. PUIG MV AND GULLEDGE AT. 2011. Serotonin and Prefrontal Cortex Function: Neurons, Networks, and Circuits. Mol Neurobiol 44: 449-464.
58. PUIG MV, ARTIGAS F AND CELADA P. 2005. Modulation of the activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in vivo: involvement of serotonin and GABA. Cereb Cortex 15: 1-14.
59. RICHARD DM, DAWES MA, MATHIAS CW, ACHESON A, HILL-KAPTURCZAK N AND DOUGHERTY DM. 2009. L-Tryptophan: Basic Metabolic Functions, Behavioral Research and Therapeutic Indications. Int J Tryptophan Res 2: 45-60.
60. ROSSI F, MAIONE S AND BERRINO L. 1994. Periaqueductal gray area and cardiovascular function. Pharmacol Res 29: 27-36.
61. SILBER BY AND SCHMITT JA. 2010. Effects of tryptophan loading on human cognition, mood, and sleep. Neurosci Biobehav Rev 34: 387-407.
62. SIMPSON HB et al. 2008. A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder. Am J Psychiatry 165: 621-630.
63. STEIN DJ AND LOPEZ AG. 2011. Effects of escitalopram on sleep problems in patients with major depression or generalized anxiety disorder. Adv Ther 28: 1021-1037.
64. TITZE-DE-ALMEIDA R, SHIDA H, GUIMARÃES FS AND DEL-BEL EA. 1994. Stress-induced expression of the c-fos proto-oncogene in the hippocampal formation. Braz J Med Biol Res 27: 1083-1088.
65. VIALOU V et al. 2014. Prefrontal cortical circuit for depression- and anxiety-related behaviors mediated by cholecystokinin: role of ΔFosB. J Neurosci 34: 3878-3887.
66. WANG D, HE X, ZHAO Z, FENG Q, LIN R, SUN Y, DING T, XU F, LUO M AND ZHAN C. 2015. Whole-brain mapping of the direct inputs and axonal projections of POMC and AgRP neurons. Front Neuroanat 27: 9-40.
67. WURTMAN RJ AND WURTMAN JJ. 1986. Carbohydrate craving, obesity and brain serotonin. Appetite 7: 97-110.
68. YOUNG SN. 1996. Behavioral effects of dietary neurotransmitter precursors: basic and clinical aspects. Neurosci Biobehav Rev 20: 313-323.
69. YOUNG SN AND GAUTHIER S. 1981. Tryptophan availability and the control of 5-hydroxytryptamine and tryptamine synthesis in human CNS. Adv Exp Med Biol 133: 221-230.